New hope for stem cell transplant patients: experimental drug targets severe immune reaction
Disease control
Recruiting now
This early-stage trial tests an experimental drug called AC-003 in 24 adults who developed severe graft-versus-host disease (aGVHD) after a stem cell transplant and did not respond to standard steroids. The main goal is to check the drug's safety and how the body processes it, wh…
Phase: PHASE1 • Sponsor: Accro Bioscience (Suzhou) Limited • Aim: Disease control
Last updated May 26, 2026 11:59 UTC